Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Amgen and Praecis to develop and commercialize abarelix

March 12, 1999

New U.S. patent broadens the base of ImmunoGen's TAP technology

March 12, 1999

Techniclone enters licensing agreement for Oncolym with Schering AG

March 12, 1999

NCI to conduct further testing of Lorus anticancer compounds

March 12, 1999

Protein prenylation inhibitors under study at Pierre Fabre for use in cancer, etc.

March 11, 1999

Bristol-Myers Squibb completes U.S. filing for Orzel, the first oral treatment for colon cancer

March 11, 1999

Transgene initiates second phase II trial with Vero-IL-2 in mesothelioma

March 11, 1999

Novogen's phenolic hormone-derived anticancer drug shows potent activity against prostate cancer

March 10, 1999

Plant-derived topoisomerase II inhibitors patented by Meiji Milk

March 10, 1999

Anticancer glycosidase inhibitors related to swainsonine

March 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...